Calithera Biosciences

-$0.13 (-6.13%) As of 5:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CALA and other ETFs, options, and stocks.

About CALA

Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor.

CEO
Susan M. Molineaux
Employees
94
Headquarters
South San Francisco, California
Founded
2010

CALA Key Statistics

Market Cap
160.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
420.63K
High Today
$2.05
Low Today
$1.90
Open Price
$2.02
Volume
292.70K
52 Week High
$6.19
52 Week Low
$1.78

CALA Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, After Hours
Preview Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure